Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission
Author: Shanmuganathan, N.
Braley, J.
Yong, A.
Hiwase, D.
Yeung, D.
Ross, D.
Hughes, T.
Branford, S.
Citation: Blood, 2019; 134(1):85-89
Publisher: American Society of Hematology
Issue Date: 2019
ISSN: 0006-4971
Statement of
Naranie Shanmuganathan, Jodi A. Braley, Agnes S. M. Yong, Devendra K. Hiwase, David T. Yeung, David M. Ross, Timothy P. Hughes and Susan Branford
Abstract: Abstract not available
Keywords: Humans; Neoplasm Recurrence, Local; Fusion Proteins, bcr-abl; Antineoplastic Agents; Protein Kinase Inhibitors; Remission Induction; Algorithms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Genetic Testing
Rights: © The American Society of Hematology
RMID: 0030112892
DOI: 10.1182/blood.2019000120
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.